Ubiquitination/deubiquitination and acetylation/deacetylation: Making DNMT1 stability more coordinated

Acta Pharmacologica Sinica

Volumn 32, Issue 2, 2011, Pages 139-140

  Hong, Qi ^a   Shao, Zhi Ming ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; CYCLINE; DNA METHYLTRANSFERASE 1; DNA METHYLTRANSFERASE INHIBITOR; HISTONE DEACETYLASE 1; HISTONE DEACETYLASE INHIBITOR; PROTEIN; PROTEIN TIP60; RING FINGER PROTEIN; UBIQUITIN LIKE CONTAINING PHD AND RING FINGER DOMAIN 1 PROTEIN; UNCLASSIFIED DRUG;

ACETYLATION; ARTICLE; CANCER THERAPY; DEACETYLATION; DEUBIQUITINATION; DNA METHYLATION; ENZYME STABILITY; EPIGENETICS; HUMAN; MOLECULAR MODEL; PROTEIN MODIFICATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; UBIQUITINATION;

ACETYLATION; ANTINEOPLASTIC AGENTS; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; DRUG DELIVERY SYSTEMS; ENZYME STABILITY; HUMANS; NEOPLASMS; UBIQUITINATION;

EID: 79551657889     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1038/aps.2011.3     Document Type: Article

References (15)

1. Goll MG, Bestor TH. Eukaryotic cytosine methyltransferases. Annu Rev Biochem 2005; 74: 481-514.
2. Ooi SK, Bestor TH. Cytosine methylation: remaining faithful. Curr Biol 2008; 18: R174-6.
3. Bostick M, Kim JK, Est've PO, Clark A, Pradhan S, Jacobsen SE. UHRF1 plays a role in maintaining DNA methylation in mammalian cells. Science 2007; 317: 1760-4.
4. Sharif J, Muto M, Takebayashi S, Suetake I, Iwamatsu A, Endo TA, et al. The SRA protein Np95 mediates epigenetic inheritance by recruiting Dnmt1 to methylated DNA. Nature 2007; 450: 908-12.
5. Rober t MF, Morin S, Beaulieu N, Gauthier F, Chute IC, Barsalou A, et al. DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells. Nat Genet 2003; 33: 61-5.
6. Brown KD, Rober tson KD. DNMT1 knockout delivers a strong blow to genome stability and cell viability. Nat Genet 2007; 39: 289-90.
7. De Marzo AM, Marchi VL, Yang ES, Veeraswamy R, Lin X, Nelson WG. Abnormal regulation of DNA methyltransferase expression during colorectal carcinogenesis. Cancer Res 1999; 59: 3855-60.
8. Agoston AT, Argani P, Yegnasubramanian S, De Marzo AM, Ansari-Lari MA, Hicks JL, et al. Increased protein stability causes DNA methyltransferase 1 dysregulation in breast cancer. J Biol Chem 2005; 280: 18302-10.
9. Kruse JP, Gu W. Modes of p53 regulation. Cell 2009; 137: 609-22.
10. Est've PO, Chin HG, Benner J, Feeher y GR, Samaranayake M, Horwitz GA, et al. Regulation of DNMT1 stability through SET7-mediated lysine methylation in mammalian cells. Proc Natl Acad Sci USA 2009; 106: 5076-81.
11. Azad N, Iyer A, Vallyathan V, Wang L, Castranova V, Stehlik C, et al. Role of oxidative/nitrosative stress-mediated Bcl-2 regulation in apoptosis and malignant transformation. Ann N Y Acad Sci 2010; 1203: 1-6.
12. Zhou Q, Agoston AT, Atadja P, Nelson WG, Davidson NE. Inhibition of histone deacetylases promotes ubiquitin-dependent proteasomal degradation of DNA methyltransferase 1 in human breast cancer cells. Mol Cancer Res 2008; 6: 873-83.
13. Du Z, Song J, Wang Y, Zhao Y, Guda K, Yang S, et al. DNMT1 stability is regulated by proteins coordinating deubiquitination and acetylation-driven ubiquitination. Sci Signal 2010; 3: ra80.
14. Karberg S. Switching on epigenetic therapy. Cell 2009; 139: 1029-31.
15. Szyf M. Towards a pharmacology of DNA methylation. Trends Pharmacol Sci 2001; 22: 350-4.